Literature DB >> 23770426

Fish oil provides robust and sustained memory recovery after cerebral ischemia: influence of treatment regimen.

Cristiano Correia Bacarin1, Marco Aurélio Mori, Emilene Dias Fiuza Ferreira, Cássia Valério Romanini, Rúbia Maria Weffort de Oliveira, Humberto Milani.   

Abstract

We previously reported that long-term treatment with fish oil (FO) facilitates memory recovery after transient, global cerebral ischemia (TGCI), despite the presence of severe hippocampal damage. The present study tested whether this antiamnesic effect resulted from an action of FO on behavioral performance itself, or whether it resulted from an anti-ischemic action. Different treatment regimens were used that were distinguished from each other by their initiation or duration with regard to the onset of TGCI and memory assessment. Naive rats were trained in an eight-arm radial maze, subjected to TGCI (4-VO model, 15 min), and tested for memory performance up to 6 weeks after TGCI. Fish oil (docosahexaenoic acid, 300 mg/kg/day) was given orally according to one of the following regimens: regimen 1 (from 3 days prior to ischemia until 4 weeks post-ischemia), regimen 2 (from 3 days prior to ischemia until 1 week post-ischemia), and regimen 3 (from week 2 to week 5 post-ischemia). When administered according to regimens 1 and 2, FO abolished amnesia completely. This effect persisted for at least 5 weeks after discontinuing the treatment. Such an effect did not occur, however, in the group treated according to regimen 3. Hippocampal and cortical damage was not alleviated by FO. The present results demonstrate that FO-mediated memory recovery (or preservation) following TGCI is a reproducible, robust, and long-lasting effect. Moreover, such an effect was found with a relatively short period of treatment, provided it covered the first days prior to and after ischemia. This suggests that FO prevented amnesia by changing some acute, ischemia/reperfusion-triggered process and not by stimulating memory performance on its own.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Docosahexaenoic acid; Fish oil; Functional recovery; Global cerebral ischemia; Memory deficit; Neurodegeneration

Mesh:

Substances:

Year:  2013        PMID: 23770426     DOI: 10.1016/j.physbeh.2013.06.001

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  5 in total

1.  Plasma Lipid Mediators Associate With Clinical Outcome After Successful Endovascular Thrombectomy in Patients With Acute Ischemic Stroke.

Authors:  Jiheng Hao; Yao Feng; Xin Xu; Long Li; Kun Yang; Gaolei Dai; Weiwei Gao; Meng Zhang; Yaming Fan; Tengkun Yin; Jiyue Wang; Bin Yang; Liqun Jiao; Liyong Zhang
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

2.  Docosahexaenoic acid confers enduring neuroprotection in experimental stroke.

Authors:  Sung-Ha Hong; Ludmila Belayev; Larissa Khoutorova; Andre Obenaus; Nicolas G Bazan
Journal:  J Neurol Sci       Date:  2013-12-31       Impact factor: 3.181

3.  Resolvin D2 protects against cerebral ischemia/reperfusion injury in rats.

Authors:  Gang Zuo; Dongping Zhang; Rutao Mu; Haitao Shen; Xiang Li; Zhong Wang; Haiying Li; Gang Chen
Journal:  Mol Brain       Date:  2018-02-13       Impact factor: 4.041

Review 4.  The Role of Resolvins: EPA and DHA Derivatives Can Be Useful in the Prevention and Treatment of Ischemic Stroke.

Authors:  Nikola Tułowiecka; Dariusz Kotlęga; Piotr Prowans; Małgorzata Szczuko
Journal:  Int J Mol Sci       Date:  2020-10-15       Impact factor: 5.923

Review 5.  Neuroinflammation in Ischemic Stroke: Inhibition of cAMP-Specific Phosphodiesterases (PDEs) to the Rescue.

Authors:  Laura Ponsaerts; Lotte Alders; Melissa Schepers; Rúbia Maria Weffort de Oliveira; Jos Prickaerts; Tim Vanmierlo; Annelies Bronckaers
Journal:  Biomedicines       Date:  2021-06-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.